Date Field | Doc. No. | Description (Pages) |
---|
Sep 26, 2023 | 9 | STIPULATION and ORDER of Dismissal without Prejudice. Signed by Judge Madeline Cox Arleo on 9/26/2023. (dam) (Entered: 09/26/2023) (2) |
Apr 13, 2023 | 8 | ANSWER to Counterclaim by ENDO PAR INNOVATION COMPANY, LLC, PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC.(RHOAD, ROBERT) (Entered: 04/13/2023) (26) |
Mar 27, 2023 | 7 | LETTER ORDER: Initial Conference set for 5/25/2023 at 10:30 AM before Magistrate Judge James B. Clark. Signed by Magistrate Judge James B. Clark on 3/27/2023. (seb) (Entered: 03/27/2023) (5) |
Mar 23, 2023 | 5 | DEFENDANTS' ANSWER to Complaint , Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by CIPLA LIMITED, CIPLA USA, INC..(CONROY, REBEKAH) (Entered: 03/23/2023) (30) |
Mar 23, 2023 | 6 | Corporate Disclosure Statement by CIPLA LIMITED, CIPLA USA, INC.. (CONROY, REBEKAH) (Entered: 03/23/2023) (3) |
Mar 7, 2023 | N/A | Judge Madeline Cox Arleo and Magistrate Judge James B. Clark added. (ps) (Entered: 03/07/2023) (0) |
Mar 7, 2023 | 3 | SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw, ) (Entered: 03/07/2023) (2) |
Mar 7, 2023 | 4 | AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint) (mxw, ) (Entered: 03/07/2023) (0) |
Feb 28, 2023 | 1 | COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14119932) , Related Case Selected, filed by PAR PHARMACEUTICAL, INC., ENDO PAR INNOVATION COMPANY, LLC, PAR STERILE PRODUCTS, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet)(RHOAD, ROBERT) (Entered: 02/28/2023) (0) |
Feb 28, 2023 | 2 | Corporate Disclosure Statement by ENDO PAR INNOVATION COMPANY, LLC, PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC identifying Endo International PLC as Corporate Parent.. (RHOAD, ROBERT) (Entered: 02/28/2023) (2) |